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INTRODUCTION 
Breast cancer is the most commonly diagnosed cancer and 
leading cause of cancer death in women worldwide, accounting 
for 25.1% (1.67 million) of total new cancer cases and 14.7% 
(521,907) of total cancer deaths in 2012 [1]. Age-standardized 
incidence and mortality rates are between 19.3–89.9 and 6.3–
17.5 per 100,000 population, respectively [1]. Reproductive and 
hormonal factors, age, physical inactivity, obesity, and alcohol 
consumption have been considered risk factors associated 
with the increasing incidence of breast cancer [2,3]. Recently, 
the relationship between lifestyle, dietary factors and the risk 
of breast cancer have been extensively studied because diet is 
considered one of the modifiable risk factors for breast cancer.
The risk of breast cancer is affected both negatively and 
positively by dairy products through several potential mech-
anisms. The main hypothesis proposing that dairy consump-
tion decreases breast cancer risk cites the anticarcinogenic 
properties of calcium, vitamin D, butyrate, lactoferrin, and 
conjugated linoleic acid [4,5]. Dairy products are the main di-
etary sources of these compounds, and studies have suggested 
that they play a role in reducing breast cancer risk [6,7]. How-
ever, it has also been suggested that dairy products increase 
breast cancer risk. High dairy product consumption may re-
flect an overall higher dietary fat intake, particularly saturated 
fat, which in turn has been associated with higher breast cancer 
incidence. Milk also contains various factors that may affect 
human health, for example, insulin-like growth factor I (IGF-I), 
which has been shown to promote breast cancer cell growth, 
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Purpose: To date, studies investigating the association between 
dairy consumption and breast cancer in women have produced 
conflicting results. As diet is an important, modifiable factor af-
fecting cancer development, the aim of this study was to exam-
ine the association between dairy consumption and breast can-
cer risk. Methods: PubMed, Embase, and Cochrane Library data-
bases were searched with a priority for prospective cohort 
studies. Case-control studies were also considered in case of the 
absence of a cohort study. Results: We analyzed 22 prospective 
cohort studies (1,566,940 participants) and five case-control 
studies (33,372 participants). High and modest dairy consump-
tion (>600 and 400–600 g/day, respectively) significantly re-
duced the risk of breast cancer compared with low dairy con-
sumption (<400 g/day; risk ratio [RR], 0.90, 95% confidence in-
terval [CI], 0.83–0.98, and RR, 0.94, 95% CI, 0.91–0.98, respec-
tively). A significant linear relationship between dairy consump-
tion and breast cancer risk was found on dose-response analy-
sis. Subgroup analysis found that yogurt (RR, 0.91; 95% CI, 
0.83–0.99) and low-fat dairy (RR, 0.85; 95% CI, 0.75–0.96) re-
duced the risk of breast cancer, while other dairy product types 
did not. A reduced risk was observed for people in the United 
States (RR, 0.91; 95% CI, 0.83–0.99) and in those followed for 
≥10 years (RR, 0.90; 95% CI, 0.81–0.99). Additionally, the high-
est level of dairy consumption among Asians was associated 
with a reduced risk of breast cancer (odds ratio, 0.74; 95% CI, 
0.62–0.88). Conclusion: Dairy consumption was inversely associ-
ated with the risk of developing breast cancer and this effect 
was dependent on the dose, dairy-type, and time.
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estrogen, which is associated with increased mitotic activity 
and DNA replication errors, and various contaminants, such 
as potentially carcinogenic pesticides [8,9].
Although the incidence rate for female breast cancer in the 
majority of Asian countries is much lower than that in West-
ern countries, there has been a marked increase in recent 
years [1]. Furthermore, there are also etiological differences in 
breast cancer between the East and West. Thus, there is a need 
to explore the true relationship between dairy consumption 
and the risk of breast cancer in different populations.
To date, the results of various prospective studies and meta-
analyses examining associations between dairy product con-
sumption and the risk of breast cancer have been inconsistent. 
Differences in the outcomes of these studies may be partly 
due to discrepancies in dairy consumption between the differ-
ent studies. Moreover, these studies have mainly been con-
ducted in the United States or Europe, with only one Asian 
cohort from Japan. With so few prospective Asian studies 
available for analysis, we suggest that where available, case-
control studies should be assessed instead. 
In summary, the effect of different populations, differing 
types of dairy products, and possible dose-response relation-
ships on breast cancer risk remains unknown. The objective 
of this study was therefore to conduct a dose-response meta-
analysis and summarize the epidemiological evidence for any 
relationship between dairy consumption and risk of breast 
cancer. This is important because estimating breast cancer risk 
associated with dairy consumption may help to inform deci-
sion-making for physicians and public health policy.
METHODS
Search strategy
Relevant studies published until January 2014 were iden-
tified by searching PubMed, Embase, and The Cochrane Li-
brary, without language restrictions. We searched using the 
following terms: “dairy products”, “dairy”, or “milk”, in combi-
nation with the terms: “breast cancer” or “breast neoplasms”. 
This search was supplemented by a manual search of the 1994 
to 2013 Annual Meeting Proceedings of the American Society 
of Clinical Oncology. Relevant reviews and meta-analyses on 
the role of dairy intake on the risk of breast cancer were exam-
ined for potential inclusive studies. This study was performed 
according to the guidelines described in the Meta-Analysis of 
Observational Studies in Epidemiology [10].
Study selection and data collection
Citations selected from the initial search were subsequently 
screened for eligibility. For inclusion, studies were required to 
(1) have examined the relationship between dairy product 
consumption (including any type of milk, yogurt, cheese, cot-
tage cheese, and other dairy products) and the incidence risk 
of breast cancer (prospective studies) or the odds of breast 
cancer (case-control studies); (2) be prospective in nature, ex-
cept for studies from Asian countries; and (3) include suffi-
cient data for different dosage categories of dairy consump-
tion, including relative risk (RR) or odds ratio (OR), with 
corresponding 95% confidence interval (CI).
Comparisons and endpoints
We firstly divided the consumption of dairy into three 
groups: high (> 600 g/day), modest (400–600 g/day), and low 
(< 400 g/day). Then we compared the RR between high and 
low/modest consumption. We also examined the relationship 
between breast cancer risk and consumption of different dairy 
types, population, geographic area, and follow-up duration.
Dairy consumption was assessed in the original studies 
using either a food frequency questionnaire or a 24-hour 
recall data interview. Dairy items (e.g., milk, cheese, and butter) 
were converted into milk servings according to the protein 
content.
Data abstraction and quality assessment
Data abstraction and quality assessment were conducted 
independently by two reviewers (J.Z. and M.S.) using a stan-
dardized approach. A third reviewer (S.Z.) adjudicated dis-
agreements after referring to the original articles. Data re-
trieved from the reports included publication details, meth-
odological components, and the following trial characteristics: 
title, author, publication year, country in which study was 
conducted, sample size, age of subjects, follow-up duration, 
and covariates controlled for by matching or multivariate 
analysis. The number of cases/noncases or person-year data 
and adjusted RR/OR for each consumption category (together 
with corresponding 95% CI) were extracted or estimated. For 
studies that reported several multivariate adjusted RRs/ORs, 
the effect estimate was extracted after fully adjusting for po-
tential confounders. Study quality was assessed using the 
9-star Newcastle-Ottawa Scale by two investigators (J.Z. and 
M.S.) [11].
Statistical analysis
We examined the relationship between dairy consumption 
and the risk of breast cancer on the basis of the adjusted RRs/
ORs and 95% CIs reported in each study. A fixed-effect model 
was used to estimate the pooled RRs/ORs, with 95% CIs if 
there was no evidence of heterogeneity; otherwise, a random-
effect model was adopted. 
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A dose-response meta-analysis was then conducted from 
the correlated natural log of the RRs across the categories of 
dairy consumption [12]. Dairy intakes were converted from 
servings or other units into grams per day (g/day) using stand-
ard conversions from the Food Standards Agency guidelines 
[13] (1 serving=200 g; 1 cup =237 g; 1 glass=200 g), or by using 
the average intake in each quartile from the studies most 
similar to one another [13]. To derive the dose-response 
curve, dairy consumption was modeled either using the linear 
model or using restricted cubic splines with three knots at 
fixed percentiles (10%, 50%, and 90%) of the distribution. The 
p-value for nonlinearity was calculated by testing the null hy-
pothesis that the coefficient of the second spline was equal to 
zero. The details of the methods used have been described 
elsewhere [14,15].
Statistical heterogeneity among studies was evaluated using 
the χ2 test and I2 statistic. The Egger’s regression test [16], 
Begg’s test [17], and visual inspection of a funnel plot were 
performed to assess publication bias. Subgroup analyses by 
geographic area, years of follow-up, type of dairy product, and 
menopause status were performed to examine the relation-
ship between dairy consumption and breast cancer risk. Sen-
sitivity analyses were performed in two ways: first, by exclud-
ing those studies that met relatively fewer quality criteria of 
the Newcastle-Ottawa Scale ( < 7 stars), and second, by ex-
cluding the studies individually to investigate the influence of 
a single study on the overall risk estimation.
Stata V.12.0 software (Stata, College Station, USA) was used 
for all analyses, and all statistical tests were two-sided; p< 0.05 
was considered an indication of statistical significance.
RESULTS
Literature search
A flow diagram of our literature search was illustrated in 
Figure 1. As of January 2014, 1,435 records were retrieved using 
the search strategy described in the methods section. After 
reviewing the titles and abstracts, 89 articles met the inclusion 
criteria for the meta-analysis. Fifty-eight articles were exclud-
ed for the following reasons: articles were not original studies 
(editorials, comments, reviews, or meta-analyses), dairy in-
take was not measured, duplication of reports from the same 
study populations, and no data on breast cancer. In total, 27 
studies were included in this meta-analysis. Twenty-two pro-
spective studies assessing the relationship between dairy or 
milk intake and the risk of breast cancer were evaluated in the 
study. Of these, 13 examined the effect of dairy and 16 exam-
ined the effect of milk intake on breast cancer incidence. Five 
studies provided data on childhood dairy consumption, five 
examined both fermented milk and yogurt consumption, and 
six and five studies evaluated whole milk and skim milk con-
sumption, respectively. Low- and high-fat dairy consumption 
were analyzed in four and three studies, respectively, whilst 
seven studies provided data on cheese intake. Five case-con-
trol studies conducted in Asia were also included in the analy-
sis: two from Japan, two from China, and one from Iran. Two 
of these studies reported on milk intake and three on dairy in-
take.
Study characteristics
Table 1 lists the general characteristics of the 22 prospective 
(1,566,940 participants and 37,925 breast cancer cases) and five 
case-control (33,372 participants and 7,418 breast cancer cases) 
studies we included in the analysis. The prospective cohort 
studies were published between 1989 and 2013: 11 were con-
ducted in the United States, 10 in Europe, and one in Japan. 
The majority of the studies were population-based, but three 
were conducted only in nurses. Three studies were conducted 
among premenopausal women only, three among postmeno-
pausal women only, and six presented results by menopausal 
Figure 1. Selection of studies for inclusion in the meta-analysis.
1,435 Potentially relevant studies 
   identified and screened for retrieval
31 Potentially appropriate studies to 
   be included in the meta-analysis
4 Studies excluded
4 Studies without relevant outcomes
Studies included in meta-analysis
22 Prospective studies
  5 Case-control studies from Asia
1,346 Abstracts and titles excluded 
   during first screening
89 Articles reviewed in detail
58 Articles excluded
  5 Duplication
38 Dairy intake not measured
15  No original articles besides 
editorials, comments, reviews or 
meta-analysis
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status. The length of follow-up ranged from 4 to 65 years, with 
a median of 10 years. Assessment of dairy intake was not con-
sistent between studies, determined through either diet ques-
tionnaires or structured food frequency questionnaires to 
gather data. Case ascertainment also differed between studies, 
with most using medical records, whilst some used self-
reports, of which the majority were confirmed by medical re-
cords. Adjustment for potential confounding factors differed 
across studies and most risk estimates were adjusted for age, 
body mass index, family history of breast cancer, reproductive 
factors, hormone replacement therapy, and total energy intake.
Quantitative data synthesis of prospective studies
Effect of dairy product consumption on breast cancer risk
The summary of RR of breast cancer for high (> 600 g/day) 
compared with low (< 200 g/day) dairy product consumption 
and dairy subgroups is shown in Figure 2. High-level dairy 
consumption was associated with a statistically significantly 
lower risk of breast cancer (RR, 0.90; 95% CI, 0.83–0.98; 
I2 = 32.2%; p-value for heterogeneity= 0.111). The random ef-
fect model was adopted. Modest dairy consumption (400–600 
g/day) was associated with a mildly lower risk of breast cancer 
(RR, 0.94; 95% CI, 0.91–0.98; I2 = 0%; p-value for heterogene-
ity= 0.975).
A dose-response analysis revealed evidence of a linear rela-
tionship between dairy consumption and risk of breast cancer 
(p= 0.016) (Figure 3). Compared with no dairy consumption, 
the adjusted RRs were 0.97 (95% CI, 0.95–0.99) for 250 g/day, 
0.94 (95% CI, 0.89–0.99) for 500 g/day, 0.91 (95% CI, 0.85–0.98) 
for 750 g/day, and 0.88 (95% CI, 0.80–0.98) for 1,000 g/day.
Effect of milk product consumption on breast cancer
High milk consumption was not found to have a preventive 
effect on breast cancer compared to low milk consumption 
(RR, 0.94; 95% CI, 0.86–1.03; I2 = 45.8; p-value for heteroge-
neity= 0.018). As shown in Figure 4, no evidence of a linear or 
nonlinear relationship between milk consumption and risk of 
breast cancer was found.
Subgroup analysis
Subgroup analyses were stratified by dairy type, study pop-
ulation, geographic area, and follow-up period (Figure 2). We 
found that consumption of yogurt and low-fat dairy were as-
Figure 2. Combined relative risks (RRs) of the breast cancer for dairy, 
milk consumption and main subgroups (highest dairy consumption was 
deemed as >600 g/day; modest, 400–600 g/day).
CI=confidence interval.
Study
Dairy highest vs. lowest 16 0.90 (0.83, 0.98) 32.2 0.111
Dairy modest vs. lowest 15 0.94 (0.91, 0.98) 0.0 0.975
Subgroups
   Dairy type
      Whole milk 7 0.99 (0.86, 1.16) 52.5 0.049
      Low fat or skim milk 6 0.93 (0.84, 1.02) 41.1 0.131
      Yogurt 7 0.91 (0.83, 0.99) 0.0 0.991
      Cheese/butter 14 0.98 (0.89, 1.07) 43.0 0.044
      Low fat dairy 6 0.85 (0.75, 0.96) 42.7 0.121
      High fat dairy 5 1.04 (0.88, 1.23) 45.0 0.122
   Population
      Premenopause 6 0.88 (0.77, 1.00) 0.0 0.425
      Postmenopause 5 0.94 (0.86, 1.02)  16.3 0.310
      Childhood consumption 6 0.94 (0.81, 1.09) 0.0 0.788
   Geographic area
      America 9 0.91 (0.83, 0.99) 36.5 0.126
      Europe 5 0.96 (0.82, 1.12) 48.1 0.103
   Follow-up (yr)
      <10  8 0.93 (0.86, 1.01) 11.0 0.344
      ≥10  6 0.90 (0.81, 0.99) 58.4 0.034





Figure 3. Dose-response relationship between dairy consumption and 




















Figure 4. Dose-response relationship between milk consumption and 
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sociated with a significant reduction in the risk of breast can-
cer (RR yogurt, 0.91, 95% CI, 0.83–0.99, I2 = 0.0%, p-value for 
heterogeneity= 0.991; RR low fat dairy, 0.85, 95% CI, 0.75–
0.96, I2 = 42.7%, p-value for heterogeneity= 0.121). However, 
no significant reduction was observed with whole milk, skim 
milk, cheese/butter, or high-fat dairy consumption. Consider-
ing population demographics, there was a marginally reduced 
breast cancer risk in premenopausal women (RR, 0.88, 95% 
CI, 0.77–1.00, p =0.057; I2 =0%, p-value for heterogeneity 
= 0.425). No association was found between breast cancer risk 
   Hirose-POM 0.70 (0.55–0.89) 17.7
   Hirose-PRM 0.82 (0.66–1.03) 18.6
   Zhang 0.93 (0.54–1.27) 10.3
   Bao 0.83 (0.73–0.93) 23.7
   Kato-PRM 0.89 (0.65–1.21) 14.5
   Kato-POM 0.54 (0.38–0.76) 13.0
   Bahadoran 0.14 (0.04–0.38) 2.2
   Overall 0.74 (0.62–0.88) 100.0
Figure 5. The summary odds ratio (OR) of breast cancer for high level of dairy or milk product compared with low level consumption (A) and dose-
response analysis for case-control studies from Asia (B).
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Figure 6. Funnel plot of log relative risk (RR) versus standard error (s.e.) of log RRs for highest dairy versus lowest dairy consumption (A); for modest 
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and postmenopausal women or childhood dairy consump-
tion. Focusing on the study country, those evaluating the U.S. 
population demonstrated a reduced risk of breast cancer (RR, 
0.91, 95% CI, 0.83–0.99; I2 = 36.5%, p-value for heterogeneity 
= 0.126). However, no statistically significant reduction in risk 
was observed among Europeans (RR, 0.96, 95% CI, 0.82–1.12; 
I2 = 48.1%, p-value for heterogeneity= 0.103). Examining fol-
low-up duration, we identified a significantly reduced risk of 
breast cancer when subjects were followed for ≥ 10 years (RR, 
0.90, 95% CI, 0.81–0.99; I2 = 58.4%, p-value for heterogeneity 
= 0.034) (Figure 2).
Quantitative data synthesis of case-control studies from Asia
The summary of OR of breast cancer for high-level com-
pared with low-level dairy or milk product consumption is il-
lustrated in Figure 5A. A high level of dairy or milk consump-
tion was associated with a significantly lower risk of breast 
cancer (OR, 0.74, 95% CI, 0.62–0.88; I2 = 62.5%, p-value for 
heterogeneity= 0.014). The random effect model was adopted. 
Evidence of a linear relationship between dairy or milk con-
sumption and risk of breast cancer was found in the dose-
response analysis (p= 0.002) (Figure 5B). Compared with that 
for no dairy or milk consumption, the adjusted OR was 0.85 
(95% CI, 0.76–0.94) for 250 g/day, 0.71 (95% CI, 0.58–0.88) 
for 500 g/day, 0.60 (95% CI, 0.44–0.83) for 750 g/day, and 0.51 
(95% CI, 0.33–0.78) for 1,000 g/day of dairy product con-
sumption.
Sensitivity analysis
The results of a sensitivity analysis performed after exclud-
ing studies of low quality were similar to the original results 
(RR dairy, 0.89, 95% CI, 0.82–0.98; RR milk, 0.93, 95% CI, 
0.85–1.02). A sensitivity analysis investigating the influence of 
a single study on the overall risk estimate by omitting one 
study in turn suggested that overall risk estimates were not 
substantially modified by any single study, with a range from 
0.89 (95% CI, 0.82–0.97) to 0.93 (95% CI, 0.87–0.98) for total 
dairy food intake and from 0.93 (95% CI, 0.85–1.02) to 0.96 
(95% CI, 0.89–1.04) for milk intake. Excluding the single Asian 
prospective study (Japan) did not significantly change the 
results. Moreover, when this cohort was added to the analysis of 
case-control studies from Asia, the results remained consistent.
Publication bias 
The funnel plot and Egger’s test identified no significant 
publication bias in the comparison between highest and low-
est or modest and lowest dairy consumers, or the highest and 
lowest milk consumers (Figure 6). Similarly, the results of 
case-control studies showed no publication bias.
DISCUSSION
The findings of this meta-analysis, which included more 
than 1.6 million participants, indicated that dairy consump-
tion is inversely and significantly associated with the develop-
ment of breast cancer. A dose-response analysis also con-
firmed this inverse association, demonstrating a significant 
linear relationship between the amount of dairy consumed 
and breast cancer risk. Subgroup analyses suggested inverse 
associations between breast cancer risk and consumption of 
yogurt, consumption of low-fat dairy products, women from 
America, and a follow-up period of > 10 years. The case-con-
trol studies from Asia indicated that higher dairy or milk con-
sumption was associated with a 27% reduction in breast can-
cer risk. Diet is considered a modifiable risk factor for breast 
cancer. These findings may therefore help to inform decision-
making in public health policy.
Several compounds present in dairy products may be re-
sponsible for the observed association between dairy con-
sumption and breast cancer risk. Data from in vitro studies 
suggest that calcium and vitamin D exert anticarcinogenic ef-
fects on breast cancer cells [18,19]. Observational studies and 
meta-analyses have also provided evidence that vitamin D 
and calcium protect against breast cancer, especially in pre-
menopausal women [20,21]. In some countries, such as the 
United States, but not in most European countries, dairy 
products are fortified with vitamin D. This makes any associa-
tion between dairy consumption, vitamin D levels, and breast 
cancer more difficult to distinguish. One of our findings from 
the subgroup analysis showed dairy consumption in the United 
States to be significantly associated with a lower risk of breast 
cancer; this association was not found in Europeans. The dis-
crepancy in vitamin D fortification of dairy products between 
different countries may have contributed to these differing re-
sults. 
In contrast, various other compounds present in dairy 
products, such as saturated fatty acids, endogenous IGF-I and 
other potential contaminants, are considered to be potentially 
carcinogenic. Dietary fat intake has long been considered to 
increase the incidence of breast cancer [22,23]; however, it is 
thought that different types of fatty acids may contribute dif-
ferently to breast cancer risk. Whilst saturated fatty acids have 
been associated with increased breast cancer risk, no signifi-
cant association has been demonstrated for total, monounsat-
urated, or polyunsaturated fats [24,25]. By subgroup analysis, 
we found that low-fat, but not high-fat dairy consumption 
reduced the risk of breast cancer. Low-fat dairy differs from 
high-fat dairy in the content of the different types of fatty 
acids present and is produced by filtering full-fat dairy to re-
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move the majority of saturated fatty acids, while retaining un-
saturated fatty acids. This may explain the different and con-
flicting results regarding the effect of fat intake on the risk of 
breast cancer in different studies.
Subgroup analysis also showed that fermented dairy or yo-
gurt consumption was associated with a lower breast cancer 
risk. Yogurt is nutritionally rich in probiotics, protein, cal-
cium, riboflavin, vitamin B6, and vitamin B12, and has nutri-
tional benefits beyond those of milk [20]. Lactobacillus acido-
philus, a probiotic present in yogurt, may modulate the im-
mune response against breast cancer in a murine model. With 
increasing age, intestines exhibit declining levels of bifidus 
bacteria, which allows the growth of toxin-producing and, 
perhaps, cancer-inducing bacteria. Yogurt can provide probi-
otics to replenish and balance the microflora in the intestines, 
which may lower cancer risk [26]. Further, IGF-I content, 
which may increase the risk of breast cancer, is significantly 
reduced in processed dairy products by heat treatment or fer-
mentation [27]. These factors may therefore contribute to the 
observed reduction in breast cancer risk in those who con-
sume fermented dairy or yogurt.
We believe that the results of this study are more reliable 
than those recently presented in the systematic review by 
Dong et al. [28]. Although Dong et al. also showed an inverse 
association between dairy consumption and breast cancer 
risk, they only compared the highest level of dairy intake ver-
sus the lowest level to point synthesis, instead of using a dose-
response analysis, which should provide a more reliable result. 
Moreover, several large cohort studies were not included in 
their study, but are included here. Excluding these studies may 
have resulted in insufficient statistical power and publication 
bias. Further, the studies they included were largely from the 
United States and Europe. The relationship between dairy and 
breast cancer risk in Asian populations, which accounts for al-
most one-third of the world’s population, was not examined. 
Although we found few prospective studies conducted in 
Asia, we searched case-control studies to assess the relation-
ship between dairy consumption and breast cancer risk. Our 
results also demonstrated a significant protective effect of 
dairy on breast cancer risk for Asian populations. Genetic fac-
tors associated with breast cancer development in Asians dif-
fer from those in Western women. Additionally, dietary pat-
terns are different, with a lower dairy consumption among 
Asian compared to Western populations. It is possible that the 
effect of dairy consumption is overestimated in Asian popula-
tions because of the lower consumption. These results also 
suggest differing etiologies for breast cancer development in 
different populations. 
This meta-analysis has several strengths, which we believe 
increased the reliability and validity of the findings. First, 
prospective studies from the United States and Europe were 
included, providing lower recall bias and selection bias. Second, 
we assessed the relationship between dairy intake and breast 
cancer risk based on geographic area, which is important given 
the observed effect in Asian populations. Third, the dose-
response analysis included a wide range of dairy consumption 
levels, which allowed an accurate assessment of the dose-
response relationship between dairy consumption and breast 
cancer risk.
There were several possible limitations in this meta-analy-
sis, which must be considered when interpreting the results. 
First, although major potential confounders had been adjust-
ed for in most of the studies that we included, residual or un-
known confounders cannot be excluded. Meta-analysis is un-
able to resolve problems with confounding factors that could 
be inherent in the original study design. High-dairy, low-fat 
dairy, or yogurt consumers may share, or be exposed to, a 
greater number of beneficial environmental factors compared 
with low-dairy or other types of dairy consumers, such as 
good economic status, better educational opportunities, a 
greater ability to engage in physical activity, and access to a 
generally healthier lifestyle. Breast cancer is believed to result 
from the interactions between both environmental and gen-
etic factors [29,30], but few data regarding genetic factors were 
contained in the primary aggregative results. A second limita-
tion was the misclassification of dairy consumption, which 
was inevitable given that consumption of dairy was self-
reported in most studies and only a few studies updated infor-
mation on dairy consumption during follow-up. The different 
dairy classifications may have been introduced because di-
etary assessments were based on different questionnaires and 
different nutrient databases. Misreporting of high dairy con-
sumption or changes in consumption during follow-up would 
most likely lead to an incorrect estimate of the true association 
between dairy consumption and risk of breast cancer. Thirdly, 
heterogeneity may have been introduced because of method-
ological differences between studies. However, in this meta-
analysis, no significant evidence of heterogeneity was found. 
The sensitivity analyses regarding methodological differences 
have also yielded consistent results with those in the overall 
analysis. Finally, the use of case-control studies from Asia may 
provide a lower level of evidence compared to the prospective 
studies, but these were included in the analysis because there 
were too few prospective Asian studies available. A greater ef-
fect of dairy consumption on breast cancer risk was observed 
in these Asian studies compared to that found in the studies 
from United States and Europe. We propose that further pro-
spective studies should be conducted to reveal the true rela-
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tionship between dairy and breast cancer amongst Asians.
In conclusion, dairy consumption was inversely associated 
with the risk of breast cancer in a manner that appears to be 
dose-dependent, time-dependent, and dairy-type dependent 
in the United States and Europe. A large effect was also ob-
served for Asian case-control studies. Prospective studies that 
investigate gene-environment interactions are required to fur-
ther clarify the etiology of breast cancer. 
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